drugset / Trial / NCT00620425

A Study on the Effects of Repeat Doses of Intraject® Sumatriptan on Local Site Signs

NCT00620425

Phase 1 Completed 18 enrolled Zogenix, Inc.
NaSingle-groupOpen-labelTreatment

Summary

Intraject is a needle-free, single use, disposable, subcutaneous delivery system pre-filled with 6 mg sumatriptan. Healthy Individuals will be enrolled for a series of 3 injections over 2 days. Assessment of Local Site Signs will be recorded for up to 5 days, as needed.

Timeline

Start
2007-12
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Sumatriptan Unknown 6 mg Subcutaneous

Indications

No indication recorded.